GEN-MKT-18-7897-A
Dec 11, 2017 | Blogs, Software, Technology | 0 comments
The latest releases of Analyst Software 1.7 and SCIEX OS Software 1.4 introduce a new licensing model called concurrent licensing. If you want flexibility and cost savings when purchasing and using your processing software, concurrent licensing is for you.
How does it work? Concurrent licenses float through the network and are passed from user to user, machine to machine. In other words, access to the software can be granted based on the number of licenses expected to be used at the same time.
So what, you ask? Good question.
The concurrent licensing model can be significantly less costly for your organization than the single device model. This means your tier 2 and tier 3 lab analyst with lower software utilization rates can now share access easily especially when access is not needed at the same time. Get a Better Understanding of Concurrent Software Licenses >
By choosing the concurrent licensing model, your organization can be more:
Enjoy the benefits of SCIEX software solutions and take full advantage of the flexible licensing model for your processing software.
For more questions on licensing, get in touch with our software sales specialists >
In biopharmaceutical development, sequence variants (SV) are considered an inherent risk of producing complex proteins in living systems. Sequence variants are unintended changes to the amino acid sequence of a biotherapeutic and can be caused by errors in transcription or translation in the host cell, or cell culture and process conditions. Detailed analysis of SVs is important in process and product development to ensure the drug’s safety and efficacy. Even low‑level sequence variants can have significant implications for product quality, safety, and efficacy, making their accurate detection and characterization a critical requirement across development, process optimization, and regulatory submission.
CE‑SDS remains a cornerstone assay for characterizing fragmentation, aggregation, and product‑related impurities in therapeutic proteins. UV detection has been the long‑standing standard. However, it frequently struggles with baseline noise, limited sensitivity for minor fragments, and subjective integration.
At SCIEX, innovation doesn’t stop at instruments; it extends to how you interact with your LC-MS/MS or CE systems every day. That’s why we’re excited to introduce the SCIEX Now spring 2026 improvements: a set of meaningful enhancements shaped directly by your feedback.
Posted by
You must be logged in to post a comment.
Share this post with your network